Catalog
Malignant mesenchymal neoplasms
No MMS code
Link to WHO Definition
Malignant mesenchymal neoplasms – http://id.who.int/icd/entity/1965082709
A usually aggressive malignant mesenchymal cell tumour most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the tumour. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.
Parents
Children
- 2B53 Fibroblastic or myofibroblastic tumour, primary site
- 2B5J Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites
- 2B51 Osteosarcoma, primary site
- 2B5D Malignant mixed epithelial mesenchymal tumour, primary site
- 2B54 Undifferentiated pleomorphic sarcoma, primary site
- Malignant mesenchymal tumours of gallbladder or bile ducts
- 2B5K Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites
- 2B5G Myosarcoma of uterus, part not specified
- 2B50 Chondrosarcoma, primary site
- 2B52 Ewing sarcoma, primary site
- Malignant mesenchymal tumour of the duodenum
- 2B5F Sarcoma, not elsewhere classified, primary site
- Epithelioid haemangioendothelioma
- 2B59 Liposarcoma, primary site
- 2B58 Leiomyosarcoma, primary site
- 2B57 Kaposi sarcoma, primary site
- Malignant mesenchymal tumour of oesophagus
- 2B56 Angiosarcoma, primary site
- Malignant neoplasm musculoskeletal
- Malignant mesenchymal tumour of anus or anal canal
- 2B5A Synovial sarcoma, primary site
- 2B5H Well differentiated lipomatous tumour, primary site
- Malignant mesenchymal tumour of rectum
- 2B55 Rhabdomyosarcoma, primary site
- 2B5B Gastrointestinal stromal tumour, primary site
- 2B5E Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site
- 2B5C Endometrial stromal sarcoma, primary site